21 Feb, EOD - Indian

SENSEX 75311.06 (-0.56)

Nifty 50 22795.9 (-0.51)

Nifty Bank 48981.2 (-0.72)

Nifty IT 40544.5 (-0.79)

Nifty Midcap 100 50486.2 (-1.32)

Nifty Next 50 60466.8 (-0.94)

Nifty Pharma 20385.65 (-1.92)

Nifty Smallcap 100 15636.9 (-0.70)

21 Feb, EOD - Global

NIKKEI 225 38776.94 (0.26)

HANG SENG 23477.92 (3.99)

S&P 6041.75 (-1.74)

Login/Signup
LOGIN HERE
Cancel

companylogoInd-Swift Laboratories Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 532305 | NSE Symbol : INDSWFTLAB | ISIN : INE915B01019 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
06-Feb-2025 13-Feb-2025 Quarterly Results IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve unaudited financial results on standalone and consolidated basis for the quarter and nine months ended 31/12/2024. IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31, 2024. The meeting was scheduled to be held on 12/02/2025, however, the meeting could not be conducted due to want of quorum. Therefore, the Board Meeting has been adjourned until tomorrow i.e., Thursday, 13/02/2025. (As per BSE Announcement Dated on 12/02/2025) Outcome of the adjourned Board Meeting held on 13/12/2024 (As Per BSE Announcement Dated on: 13/02/2025)
06-Nov-2024 11-Nov-2024 Quarterly Results IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve un-audited Financial Results of the Company for the Quarter and half year ended September 30 2024. Outcome of the Board Meeting held on 11/11/2024 to consider and approve inter-alia the financial results for quarter and half year ended 30.09.2024 (As per BSE Announcement Dated on 11/11/2024)
01-Aug-2024 12-Aug-2024 Quarterly Results IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve un-audited Financial Results of the Company for the Quarter ended June 30 2024.
24-Jun-2024 27-Jun-2024 Preferential Issue Issue Of Warrants & Preferential Issue of shares Please refer attached pdf (As per BSE Announcement Dated on 27/06/2024)
02-May-2024 13-May-2024 Accounts IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Year ended March 31 2024. Outcome of Board Meeting held on May 13, 2024 Please refer attached pdf (As Per BSE Announcement Dated on 13/05/2024)
30-Mar-2024 30-Mar-2024 Others please refer attached pdf.
18-Mar-2024 18-Mar-2024 Issue of Debentures Please refer attached PDF
08-Mar-2024 08-Mar-2024 Scheme of Amalgamation Please refer attached PDF.
05-Mar-2024 05-Mar-2024 Others Please refer attached PDF.
29-Jan-2024 12-Feb-2024 Quarterly Results IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve IND-SWIFT LABORATORIES LTD. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve unaudited standalone and consolidated financial statements for the quarter and nine months ended on December 31 2023. Outcome of the Board Meeting. Financial Results for the quarter ended 31st December, 2023. (As Per BSE Announcement Dated on 12/02/2024)
30-Oct-2023 07-Nov-2023 Quarterly Results IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited standalone and consolidated financial statements for the quarter and half year ended on September 30 2023. Outcome Of Board Meeting held on 07.11.2023 Financial Results for the quarter and half year ended on 30.09.2023. (As Per BSE Announcement Dated on 07/11/2023) Corrigendum to the Financial Results for the quarter and half year ended 30th September, 2023 (As Per BSE Announcement dated on 08.11.2023)
25-Sep-2023 25-Sep-2023 Scheme of Amalgamation Disclosure under Regulation 30 regarding Scheme of arrangement for Amalgamation
06-Sep-2023 06-Sep-2023 EGM Outcome of Board Meeting Corrigendum to disclosure dated 6th September, 2023
31-Aug-2023 31-Aug-2023 AGM Outcome of Board Meeting held on 31st August, 2023
31-Jul-2023 09-Aug-2023 Quarterly Results IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve IND-SWIFT LABORATORIES LTD. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve Standalone and Consolidated Un-Audited Financial Results of the Company for the First Quarter (Q1) Ended June 30 2023. Outcome of Board Meeting held on 9th August, 2023 Financial Results (As per BSE Announcement Dated on 09/08/2023)
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +